Short Notes - Guyton and Hall Medical Physiology

1. Intrinsic Pathway of Coagulation

1. Factor XII activation: Blood contact with exposed collagen, damaged endothelium, or foreign surfaces activates Factor XII (Hageman factor) to Factor XIIa.
2. Factor XI activation: Factor XIIa, along with high-molecular-weight kininogen (HMWK) and prekallikrein, activates Factor XI to Factor XIa.
3. Factor IX activation: Factor XIa, in the presence of Ca²+, activates Factor IX to Factor IXa.
4. Factor X activation (tenase complex): Factor IXa combines with Factor VIIIa, platelet phospholipids, and Ca²+ to form the "tenase complex," which activates Factor X to Factor Xa.
5. Prothrombin activator formation: Factor Xa combines with Factor Va, phospholipids, and Ca²+ to form the prothrombinase complex (prothrombin activator).
6. Thrombin and fibrin: Prothrombin activator converts prothrombin to thrombin; thrombin then converts fibrinogen to fibrin monomers, which polymerize into a stable fibrin clot (stabilized by Factor XIIIa).

2. Role of B Lymphocytes

• Neutralize toxins and viruses
• Opsonize bacteria (facilitate phagocytosis)
• Activate complement
• Cause agglutination and precipitation of antigens

3. Blood Group Classification and Erythroblastosis Foetalis

Blood Group Classification (ABO System)

Erythroblastosis Foetalis

• Hemolysis and severe anemia
• Jaundice (kernicterus if bilirubin is high)
• Hydrops fetalis (generalized edema from anemia)
• Erythroblastosis (release of immature RBCs into circulation)

4. Mismatched Blood Transfusion

1. Agglutination: Clumping of donor RBCs blocks small blood vessels, causing circulatory obstruction.
2. Hemolysis: Free hemoglobin is released into plasma (hemoglobinemia).
3. Renal failure: Free hemoglobin precipitates in renal tubules, causing tubular blockage and acute renal failure - the most dangerous complication.
4. Hemoglobinuria: Hemoglobin appears in urine (dark urine).
5. Jaundice: Excess bilirubin from RBC breakdown causes jaundice.
6. Anaphylaxis/shock: Antigen-antibody complexes can trigger complement activation and systemic inflammatory response.
7. Death: Severe cases can be fatal from circulatory collapse and renal failure.

5. Functions of Plasma Proteins

Functions:

1. Colloid Osmotic Pressure (Albumin): Albumin (the most abundant plasma protein) is primarily responsible for maintaining plasma colloid osmotic pressure (~25 mmHg), which prevents fluid loss from capillaries into the interstitium. Loss of albumin leads to generalized edema.
2. Immunity (Globulins): Gamma globulins (immunoglobulins) function as antibodies, providing both innate and acquired immunity. Alpha and beta globulins act as carrier proteins (e.g., transferrin for iron, ceruloplasmin for copper).
3. Coagulation (Fibrinogen): Fibrinogen polymerizes into fibrin threads during clotting, forming the fibrin clot that seals ruptured vessels.
4. Enzymatic Functions: Globulins perform various enzymatic functions in plasma.
5. Labile Protein Reserve: Plasma proteins serve as a quickly available source of amino acids. Tissue macrophages can phagocytize whole plasma proteins (pinocytosis), digest them, and release amino acids for tissue protein synthesis. This reservoir is mobilized during starvation or severe illness.
6. Buffering: Plasma proteins act as buffers, contributing to acid-base balance.
7. Transport: Carrier proteins (alpha and beta globulins) transport hormones, lipids, metals, and drugs in plasma.

6. Immunity - Definition, Primary and Secondary Immune Response, Role in Vaccination, Role of T Cells

Definition of Immunity

Types of Acquired Immunity

• Humoral immunity (B-cell immunity): Mediated by circulating antibodies produced by B lymphocytes/plasma cells.
• Cell-mediated immunity (T-cell immunity): Mediated by activated T lymphocytes.

Primary Immune Response

Secondary Immune Response

Role in Vaccination

Role of T Cells

• T-helper cells (CD4+): Activate B cells, enhance antibody production, stimulate cytotoxic T cells; are the major amplifiers of immune responses.
• Cytotoxic T cells (CD8+): Directly kill virus-infected cells, cancer cells, and foreign graft cells by releasing perforins and granzymes; also release lymphokines.
• Regulatory T cells: Suppress immune responses and maintain self-tolerance.
• Memory T cells: Persist for life, enabling rapid secondary responses.

7. Landsteiner's Law and Importance of Rh Blood Group

Landsteiner's Law

1. If an agglutinogen (antigen) is present on the RBCs, the corresponding agglutinin (antibody) is absent from the plasma.
2. If an agglutinogen is absent from the RBCs, the corresponding agglutinin is present in the plasma.

• Blood group A: A antigen present on RBCs, anti-B antibody in plasma.
• Blood group O: No antigens on RBCs, both anti-A and anti-B antibodies in plasma.
• Blood group AB: Both A and B antigens, no antibodies.

Importance of Rh Blood Group

1. Blood Transfusion: Rh-negative individuals who receive Rh-positive blood develop anti-Rh antibodies. A second transfusion of Rh-positive blood may cause a severe hemolytic transfusion reaction.
2. Erythroblastosis Fetalis: As described above, Rh incompatibility between Rh-negative mother and Rh-positive fetus causes hemolytic disease of the newborn.
3. Pre-transfusion Testing: Rh typing must be done before all blood transfusions and in all pregnant women.
4. Prevention: Rho(D) immune globulin (RhoGAM) prevents Rh sensitization in Rh-negative mothers.

8. CD4 Cells (T-Helper Cells)

• Th1 cells: Promote cell-mediated immunity; activate macrophages and cytotoxic T cells; secrete IFN-gamma and IL-2.
• Th2 cells: Promote humoral immunity; stimulate B-cell antibody production; secrete IL-4, IL-5, IL-13.
• Treg cells: Regulatory T cells; suppress immune responses; maintain peripheral tolerance.

1. Activate B lymphocytes to produce antibodies (essential for humoral immunity).
2. Activate and amplify cytotoxic T-cell responses.
3. Stimulate macrophage phagocytic activity.
4. Release cytokines (interleukins, lymphokines) that coordinate immune responses.
5. Form CD4+ memory T cells for rapid secondary responses.

9. Platelets - Normal Count and Functions

Normal Count

• Thrombocytopenia: <150,000/μL (increased bleeding risk)
• Thrombocytosis: >450,000/μL

Structure

Functions:

1. Vascular spasm: Release thromboxane A2, which causes vasoconstriction to reduce blood flow from injured vessels.
2. Platelet plug formation: On exposure to damaged vessel wall collagen, platelets adhere (via von Willebrand factor), become activated, swell, and release ADP and thromboxane A2 - recruiting more platelets in a positive feedback loop to form a platelet plug. This alone seals minor vascular injuries.
3. Blood coagulation: Platelet phospholipids provide a catalytic surface for the activation of clotting factors (especially Factors IX and X). Fibrin-stabilizing factor (Factor XIII) from platelets strengthens the clot.
4. Clot retraction: Platelets contract using thrombostenin, pulling fibrin strands together and retracting the clot.
5. Vascular repair: PDGF from platelets stimulates growth of endothelial cells, smooth muscle cells, and fibroblasts to repair vessel walls.

10. Erythroblastosis Foetalis - Features and Treatment

Pathophysiology

• Rh-positive fetal RBCs enter maternal circulation during delivery (or sometimes during pregnancy).
• The Rh-negative mother mounts a primary immune response, producing anti-Rh IgG antibodies.
• In subsequent Rh-positive pregnancies, the secondary immune response produces large quantities of anti-Rh IgG, which cross the placenta and destroy fetal RBCs.

Features (Clinical Manifestations):

1. Anemia: Severe hemolytic anemia due to destruction of fetal RBCs; can cause high-output cardiac failure.
2. Jaundice: Excess bilirubin from hemolysis; unconjugated bilirubin crosses the blood-brain barrier causing kernicterus (bilirubin encephalopathy) with brain damage.
3. Hydrops fetalis: Severe anemia leads to heart failure, generalized edema (ascites, pleural effusions, subcutaneous edema).
4. Erythroblastosis: Bone marrow and extramedullary hematopoiesis (liver, spleen) release immature nucleated RBCs (erythroblasts) into circulation - hence the name.
5. Hepatosplenomegaly: From extramedullary hematopoiesis.
6. Stillbirth: In severe cases, intrauterine death may occur.

Treatment:

1. Phototherapy: Blue light converts unconjugated bilirubin to water-soluble isomers excreted in bile/urine; used for mild-moderate jaundice.
2. Exchange transfusion: Complete replacement of baby's blood with Rh-negative blood removes sensitized RBCs, antibodies, and bilirubin.
3. Intrauterine transfusion: In severe anemia detected prenatally, Rh-negative packed RBCs are transfused into the umbilical vein.
4. Prevention (most important): Rho(D) immune globulin (RhoGAM/anti-D) injected to all Rh-negative mothers at 28 weeks gestation and within 72 hours of delivery. The exogenous anti-D antibodies destroy any fetal Rh-positive RBCs in maternal circulation before sensitization can occur.

11. Bleeding Time, Clotting Time - Definitions; Intrinsic Pathway

Bleeding Time (BT)

• Normal: 1-6 minutes (Duke method - earlobe/fingertip) or 2-9 minutes (Ivy method)
• Prolonged in: Thrombocytopenia, platelet function disorders (e.g., von Willebrand disease, aspirin use)
• Tests: vascular integrity + platelet count + platelet function

Clotting Time (CT)

• Normal: 4-8 minutes (Lee-White method)
• Prolonged in: Deficiencies of intrinsic pathway factors (VIII, IX, XI, XII), heparin therapy, hemophilia

Intrinsic Pathway (Description)

1. Factor XII (Hageman factor) + HMWK + Prekallikrein → Factor XIIa (surface activation)
2. Factor XIIa → Factor XIa (activates Factor XI)
3. Factor XIa + Ca²+ → Factor IXa (activates Factor IX)
4. Factor IXa + Factor VIIIa + Phospholipid + Ca²+ → Factor Xa (tenase complex)
5. Factor Xa + Factor Va + Phospholipid + Ca²+ → Prothrombin Activator (prothrombinase complex)
6. Prothrombin → Thrombin (by prothrombin activator)
7. Fibrinogen → Fibrin monomers → Fibrin clot (stabilized by Factor XIIIa)

12. Coagulation - Definition and Flowchart; Bleeding and Clotting Disorders

Definition of Coagulation

Flowchart of Coagulation

INTRINSIC PATHWAY          EXTRINSIC PATHWAY
(Contact with collagen)    (Tissue trauma → Tissue Factor)
      ↓                          ↓
XII → XIIa              VII + Tissue Factor + Ca²+
      ↓                          ↓
XI → XIa                    X → Xa
      ↓                          ↓
IX + VIIIa + PL + Ca²+ → IXa
      ↓
    X → Xa
         ↘              ↙
    COMMON PATHWAY
    Xa + Va + PL + Ca²+ → Prothrombin Activator
              ↓
    Prothrombin → Thrombin (+ Ca²+)
              ↓
    Fibrinogen → Fibrin monomers
              ↓ (Factor XIIIa)
         Stable Fibrin Clot

Bleeding vs. Clotting Disorders

13. Immunity - Definition, Classification; Cell-Mediated Immunity; Humoral Immunity; Vaccination

Definition

Classification

• Present from birth; no prior exposure needed
• Includes: skin barrier, mucous membranes, phagocytes (neutrophils, macrophages), complement, NK cells, inflammatory response
• Does not improve with repeated exposure

1. Active immunity: Body produces its own antibodies/T cells in response to an antigen; long-lasting.
   • Natural: after actual infection
   • Artificial: after vaccination
2. Passive immunity: Preformed antibodies transferred from another individual; short-lived (weeks).
   • Natural: maternal IgG across placenta; IgA in breast milk
   • Artificial: injection of antiserum or immunoglobulins

Humoral (B-cell) Immunity

• Mediated by antibodies produced by plasma cells (derived from B lymphocytes)
• Effective against extracellular pathogens, bacterial toxins, and viruses in blood
• Antibodies neutralize, opsonize, agglutinate, precipitate antigens, and activate complement
• Memory B cells enable rapid secondary responses

Cell-Mediated (T-cell) Immunity

• Mediated by activated T lymphocytes (no antibody production)
• Effective against intracellular pathogens (viruses, mycobacteria), cancer cells, fungi, and foreign grafts
• Cytotoxic T cells (CD8+): Directly kill target cells via perforin and granzyme
• T-helper cells (CD4+): Amplify both humoral and cell-mediated responses; secrete cytokines
• T-cell memory provides long-lasting protection

Vaccination

1. Introducing attenuated/killed pathogens or their antigens (or mRNA in modern vaccines)
2. Stimulating primary immune response with lymphocyte clonal expansion and memory cell formation
3. On subsequent natural exposure, the secondary (anamnestic) response rapidly eliminates the pathogen before disease develops
4. Booster doses increase memory cell populations and antibody titers

14. Clotting - Definition; Mechanism of Blood Coagulation Flowchart; Anticoagulants

Definition of Clotting (Blood Coagulation)

Mechanism of Blood Coagulation - Flowchart

EXTRINSIC PATHWAY                   INTRINSIC PATHWAY
Tissue damage                       Surface contact (collagen)
     ↓                                      ↓
Tissue Factor (III)               XII + HMWK + Prekallikrein
+ Factor VII + Ca²+                         ↓ XIIa
     ↓                                 XI → XIa
Factor X activated                         ↓
                                     IX → IXa
                                   + VIIIa + PL + Ca²+
                                           ↓
           ←——— COMMON PATHWAY ————→
               X → Factor Xa
               + Factor Va + PL + Ca²+
                        ↓
              Prothrombin Activator
                        ↓ (Ca²+)
              Prothrombin → THROMBIN
                        ↓
              Fibrinogen → Fibrin monomers
                        ↓ (Factor XIIIa)
                  Stable FIBRIN CLOT

Anticoagulants

1. Heparin: Present in mast cells; activates antithrombin III (blocks thrombin and factors IXa, Xa, XIa, XIIa)
2. Antithrombin III: Inactivates thrombin and other serine proteases
3. Protein C and Protein S: Inactivate Factors Va and VIIIa
4. Thrombomodulin: On endothelium; binds thrombin → activates Protein C
5. Prostacyclin (PGI2): Inhibits platelet aggregation

1. Heparin: Parenteral; rapidly activates antithrombin III; monitored by APTT
2. Warfarin (oral): Inhibits Vitamin K-dependent factors (II, VII, IX, X, Protein C and S); monitored by PT/INR
3. Citrate/Oxalate: Used in blood banks; chelate Ca²+, preventing coagulation in vitro

15. WBC - Classification, Morphology, Function

Classification

1. Neutrophils (62%) - multilobed nucleus, fine pink granules
2. Eosinophils (2.3%) - bilobed nucleus, large red-orange granules
3. Basophils (0.4%) - irregular nucleus, large dark blue/purple granules

Morphology

Functions

• B lymphocytes: Produce antibodies (humoral immunity)
• T lymphocytes: Cell-mediated immunity (cytotoxic, helper, regulatory)
• NK cells: Kill virus-infected and tumor cells without prior sensitization

16. Erythropoiesis

Sites of Production

• Embryo (early): Yolk sac
• Mid-fetal life: Liver (primary), spleen, and lymph nodes
• Last trimester to birth and throughout life: Red bone marrow
• In adults, active marrow is found in membranous bones (vertebrae, sternum, ribs, ilia). Long bone marrow becomes fatty and inactive by age 20.

Stages of Erythropoiesis

Multipotent Hematopoietic Stem Cell (MPHSC)
        ↓
Committed Progenitor → CFU-E (Colony Forming Unit - Erythrocyte)
        ↓
    Proerythroblast (large cell, basophilic, no Hb yet)
        ↓
    Basophilic Erythroblast (ribosome-rich; Hb synthesis begins)
        ↓
    Polychromatophilic Erythroblast (pink-blue; Hb increasing)
        ↓
    Orthochromatic Erythroblast (Normoblast; mainly pink/red; nucleus shrinking)
        ↓
    Reticulocyte (nucleus expelled; residual mRNA; released into blood)
        ↓ (1-2 days in blood)
    Mature Erythrocyte (biconcave disc; no nucleus; filled with Hb)

Regulation by Erythropoietin (EPO)

• Hypoxia stimulates the kidney (and liver to a lesser extent) to release erythropoietin (EPO)
• EPO acts on CFU-E and proerythroblasts to stimulate proliferation and differentiation
• EPO increases reticulocyte release from bone marrow
• Also promotes iron incorporation into Hb

Requirements for Erythropoiesis

1. Iron: Essential for heme synthesis (hemoglobin); stored as ferritin; transported by transferrin
2. Vitamin B12: Required for DNA synthesis (nuclear maturation); deficiency causes megaloblastic anemia
3. Folic acid: Required for thymidine synthesis in DNA; deficiency also causes megaloblastic anemia
4. Intrinsic factor: Secreted by gastric parietal cells; required for B12 absorption (absent in pernicious anemia)
5. Protein, copper, Vitamin C, and other cofactors

Normal Values

• RBC count: 5 million/μL (male), 4.5 million/μL (female)
• Lifespan of RBC: ~120 days
• Reticulocyte count: 0.5-1.5% of RBCs